戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  institution is 'MRC Weatherall Institute of Molecular Medicine'.
2  innovative platform in chemical biology and molecular medicine.
3 able aptamers and enzymes for exobiology and molecular medicine.
4  in the fields of molecular cell biology and molecular medicine.
5 res in many areas of chemistry, biology, and molecular medicine.
6  fully realizing the promise of personalized molecular medicine.
7 rder emphasizes the potential and promise of molecular medicine.
8                       This is the promise of molecular medicine.
9 on of WBP2 and how they can be exploited for molecular medicine.
10  implemented as a gene-specific approach for molecular medicine.
11 ngineering as well as disease mechanisms and molecular medicine.
12 m at the interface of chemistry, biology and molecular medicine.
13 le cell disease was an important landmark in molecular medicine.
14 neration and as vehicles for cell therapy in molecular medicine.
15 ep in fulfilling the promise of personalized molecular medicine.
16 agnostics has the potential to revolutionize molecular medicine.
17 ong the priorities in this emerging field of molecular medicine.
18 have demonstrated considerable potential for molecular medicine.
19 ently being investigated as another tool for molecular medicine.
20 ion of single-base changes is fundamental to molecular medicine.
21 id delivery systems, advancing the future of molecular medicine.
22  School and an endowed chair in cellular and molecular medicine.
23 hanced detection of biomarkers in cancer and molecular medicine.
24 t one of the great success stories of modern molecular medicine.
25 prove the delivery and efficacy of nano- and molecular medicines.
26 ression, and treatment in our current era of molecular medicine and individualized patient care.
27 ls, is of relevance in such diverse areas as molecular medicine and materials science.
28 gs are consistent with PML.The Laboratory of Molecular Medicine and Neuroscience (LMMN), National Ins
29 orbent assays performed at the Laboratory of Molecular Medicine and Neuroscience, National Institute
30 orm with potential for broad applications in molecular medicine and pandemic preparedness.
31 t only introduced a new era in the fields of molecular medicine and targeted therapies but may also p
32 icantly enhanced by technical innovations in molecular medicine and the integration of cutaneous biol
33 cross a tissue with emerging applications in molecular medicine and tumor diagnostics.
34     The merging fields of molecular biology, molecular medicine, and imaging modalities may provide t
35 hese links may be exploited for novel modern molecular medicine approaches.
36 amounts of data emerging from experiments in molecular medicine are leading to the identification of
37                 Developments in genomics and molecular medicine are rapidly improving diagnosis, and
38                                 Clinical and molecular medicines are undergoing a revolution based on
39 that this virus is of increasing interest to molecular medicine as a vector for gene delivery, relati
40  and cancer diseases, and for developing new molecular medicine-based therapies.
41                                              Molecular medicine began with Pauling's seminal work, wh
42 equirement for quantitative data analysis in molecular medicine, biotechnology, microbiology and diag
43                                              Molecular medicine can benefit greatly from antibodies t
44              High-resolution approaches from molecular medicine can provide unparalleled insight into
45 ncer biology over the last year have brought molecular medicine closer to the clinic.
46 s promise to accelerate rapidly a new era in molecular medicine, especially in the detection and disc
47  the time is right to implement personalized molecular medicine for all patients with cancer.
48 ly manipulated mammals fulfills a promise of molecular medicine: fusion of molecular biochemistry wit
49                Hypoxia imaging in support of molecular medicine has become an important success story
50                 This clinical application of molecular medicine has been based on a growing molecular
51       The ongoing transition from empiric to molecular medicine has engendered a need for correspondi
52                           Recent progress in molecular medicine has provided important tools to ident
53                             Breakthroughs in molecular medicine have positioned the amyloid-B (AB) pa
54 demic programs now embracing the concepts of molecular medicine (i.e., targeting changes in specific
55 nvolve the familiar challenges of delivering molecular medicines in vivo.
56 ntional procedures, surgical techniques, and molecular medicine-including gene editing and RNA-based
57                    Here their application in molecular medicine is discussed, especially with regard
58                   One important outgrowth of molecular medicine is the development of technologies fo
59                 One long-standing problem in molecular medicine is the specific identification and ab
60                His affiliation is Center for Molecular Medicine, Maine Medical Center Research Instit
61 nology that will be driven by the demands of molecular medicine, notably sensitive and specific molec
62                                              Molecular medicine requires the precise definition of dr
63 d annually among 4 distinguished nuclear and molecular medicine subject matter experts.
64 ases are increasingly important resources in molecular medicine, systems biology, and pharmacology.
65 ons, as well as lessons for other aspects of molecular medicine, the origin of which can be largely t
66                             With advances in molecular medicine, this protein is a segue to a panel o
67 e editing to the clinic and hold promise for molecular medicine to address human disease at its root.
68 erstanding of gene-nutrient interactions and molecular medicine to address potential mechanisms by wh
69  continues to be a model for applications of molecular medicine to clinical delineation, diagnosis, a
70   The MOT provides a clinical venue to allow molecular medicine to rapidly advance, answers questions
71  advances have opened a new era of precision molecular medicine to reprogram cellular physiology.
72 fic drug carriers to improve the delivery of molecular medicine to solid tumors.
73 attner (Institute of Infectious Diseases and Molecular Medicine, University of Cape Town).
74 e at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Afric
75                                              Molecular medicine will require a large number of probes